# Abridge’s 100 Million Conversations Are the Real Story Behind Its Journal Partnerships - Date: 2026-04-16 - Category: Biotech & Life Sciences Abridge announced deals with NEJM and JAMA this week. But the journals are also licensing to its competitor, and the real asset may be the 100 million patient conversations Abridge is present for each year — and what that dataset is worth. ---